Treatment of viral infections with 5‐aminolevulinic acid and light

When 5‐aminolevulinic acid (ALA) is exogenously supplied, protoporphyrin IX (PpIX) is accumulated in various cells and makes them light sensitive. The possibility of using such an approach for the treatment of viral infections was studied in this work.

[1]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[2]  H. Hönigsmann,et al.  Photodynamic therapy of epithelial skin tumours using delta‐aminolaevulinic acid and desferrioxamine , 1995, The British journal of dermatology.

[3]  J. van der Zee,et al.  Toxic dark effects of protoporphyrin on the cytochrome P-450 system in rat liver microsomes. , 1992, The Biochemical journal.

[4]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[5]  Z. Malik,et al.  Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. , 1995, Journal of photochemistry and photobiology. B, Biology.

[6]  F. Cairnduff,et al.  Photodynamic therapy of primary skin cancer: a review. , 1995, British journal of plastic surgery.

[7]  J. Justement,et al.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. , 1987, Science.

[8]  B. Chesebro,et al.  Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity , 1988, Journal of virology.

[9]  L. Braathen,et al.  Topical photodynamic therapy in verrucae. A pilot study. , 1995, Dermatology.

[10]  P. Gottlieb,et al.  Inactivation by phthalocyanine photosensitization of multiple forms of human immunodeficiency virus in red cell concentrates , 1996, Transfusion.

[11]  G. Stables,et al.  The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. , 1996, The Journal of investigative dermatology.

[12]  H. Kerl,et al.  Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1994, Journal of the American Academy of Dermatology.

[13]  J C Kennedy,et al.  Evidence of lasting functional destruction of the rat endometrium after 5-aminolevulinic acid-induced photodynamic ablation: prevention of implantation. , 1993, American journal of obstetrics and gynecology.

[14]  W. Sterry,et al.  Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.

[15]  R. G. Frank,et al.  Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. , 1996, Genitourinary medicine.

[16]  S. Iinuma,et al.  A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. , 1994, British Journal of Cancer.

[17]  Z. Malik,et al.  5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced Friend erythroleukemic cells. , 1979, Cell differentiation.